imiquimod 50 MG/ML Topical Cream

Known as: imiquimod 50 mg in 1000 mg TOPICAL CREAM [Imiquimod], IMIQUIMOD 12.5 mg in 0.25 g TOPICAL CREAM, IMIQUIMOD 5% TOP CREAM PKT 0.25GM 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1999-2018
012319992018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Die HPV-Infektion ist Ursache verschiedener benigner, prämaligner und invasiver Erkrankungen, u. a. des weiblichen Genitale. Eine… (More)
Is this relevant?
2017
2017
Rottlerin is a natural polyphenolic compound that was initially indicated as a PKCδ inhibitor. However, it was recently revealed… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2011
2011
Imiquimod, an imidazoquinoline compound, has been widely-recognized for its ability to induce both innate and adaptive immune… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
Review
2010
Review
2010
OBJECTIVE To evaluate the cost-effectiveness and treatment-cost impact of sinecatechins (Veregen) as first-line therapy against… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?
2008
2008
BACKGROUND Microbial exposure might play a key role in allergy development, but little is known about the role of Toll-like… (More)
Is this relevant?
2005
2005
INTRODUCTION Imiquimod (Aldara) is an immune response modifier approved for the topical treatment of external genital and… (More)
Is this relevant?
2003
2003
Kutane T-Zell-Lymphome umfassen eine Gruppe von Krankheiten mit dem Merkmal einer Invasion von monoklonalen T-Lymphozyten in die… (More)
Is this relevant?
2001
2001
Wir berichten über eine 75-jährige Frau mit Hauttyp I, die seit 20 Jahren an multiplen aktinischen Keratosen im Bereich von… (More)
Is this relevant?
Highly Cited
1999
Highly Cited
1999
There is a need for new, effective, and less toxic treatments for leishmaniasis, an infectious disease caused by Leishmania… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?